Physician

Ryan L Holzwarth, MD

According to 2025 Medicare claims, Ryan Holzwarth, MD (NPI: 1437102324) practices dermatology in the Minneapolis-St. Paul-Bloomington, MN-WI market, with the plurality of this provider's patient population coming from St. Croix, WI. This provider's primary affiliated billing organization is TAREEN DERMATOLOGY, P.A. (NPI: 1063782621; TIN: 454147351) and primary practice location at 54016-9914.

Holzwarth's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 758 traditional Medicare patients, billed 4,940 HCPCS/CPT codes, and received $390,426 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 1,246 prescription claims across 515 beneficiaries totaling $503,343 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 1 records totaling $21. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $214,739 to $503,343. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$195K$390K2015 Medicare payment: $147,592 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $142,594 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $149,378 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $125,479 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $37,112 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $44,320 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $84,539 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $164,327 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $201,113 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $390,426 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,2314,144$147,592
20161,1933,923$142,594
20171,2404,172$149,378
20181,1753,275$125,479
2019212642$37,112
2020264831$44,320
20213791,369$84,539
20225222,538$164,327
20235182,476$201,113
20247584,940$390,426

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$413K$825K2015 Drug cost: $214,739 (USD; Tot_Drug_Cst)2016 Drug cost: $225,685 (USD; Tot_Drug_Cst)2017 Drug cost: $213,199 (USD; Tot_Drug_Cst)2018 Drug cost: $317,733 (USD; Tot_Drug_Cst)2019 Drug cost: $63,833 (USD; Tot_Drug_Cst)2020 Drug cost: $119,779 (USD; Tot_Drug_Cst)2021 Drug cost: $348,101 (USD; Tot_Drug_Cst)2022 Drug cost: $825,079 (USD; Tot_Drug_Cst)2023 Drug cost: $633,482 (USD; Tot_Drug_Cst)2024 Drug cost: $503,343 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154771,506$214,739
20164611,752$225,685
20174911,752$213,199
20184631,543$317,733
2019249497$63,833
2020228667$119,779
2021357922$348,101
20224091,102$825,079
20234491,092$633,482
20245151,246$503,343

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
11102Biopsy of related skin growth, first growth256274$66
99203New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more225225$64
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more288376$60
11103Biopsy of related skin growth, each additional growth85128$36
17000Destruction of precancer skin growth, 1 growth144156$35

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab35980$135,449
Humira(Cf) PenAdalimumab13364$87,780
OtezlaApremilast11330$53,882
Clobetasol PropionateClobetasol Propionate1785,098$8,306
TacrolimusTacrolimus29770$4,497

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$21Boston Scientific Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ryan L. Holzwarth, MD?

Tedicare shows public-source Medicare data for Ryan L. Holzwarth, MD (NPI 1437102324), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ryan L. Holzwarth, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ryan L. Holzwarth, MD?

Ryan L. Holzwarth, MD is linked to TAREEN DERMATOLOGY, P.A. (billing NPI 1063782621) in the available physician profile data.

Does Ryan L. Holzwarth, MD have Open Payments data?

Ryan L. Holzwarth, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.